Suits Over Antibiotic Ketek Bolstered By House Inquiry Into Faulty Testing
February 15, 2008 06:14

New Jersey Law Journal reports that Plaintiffs in New Jersey and six other states who claim the antibiotic Ketek caused liver disease are getting a booster shot from a congressional inquiry into the clinical trials that led to FDA approval. On Tuesday, witnesses at a hearing before the House Committee on Energy and Commerce's Subcommittee on Oversight and Investigations testified that Ketek's trials were flawed and that the company had knowledge of flawed data even before FDA approval.

The Bush administration has declined to comply with a congressional subpoena for documents related to Sanofi-Aventis' antibiotic Ketek.
February 15, 2008 10:36

An investigative subcommittee of the House Energy and Commerce Committee sought papers used to prepare Food and Drug Administration Commissioner Andrew von Eschenbach for testimony he gave at a hearing on the drug last March. The administration's response was released yesterday by the panel.